Related Experiment Video

Updated: Jul 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Impact of adherence to statins on coronary artery disease in primary prevention

Marie-Hélène Bouchard1, Alice Dragomir, Lucie Blais

  • 1Faculty of Pharmacy, University of Montréal, Montréal, Québec, Canada.

British Journal of Clinical Pharmacology
|January 12, 2007
PubMed

Insights

High adherence to statin therapy, defined as using over 90% of prescribed doses for at least one year, significantly reduces the risk of nonfatal coronary artery disease (CAD). This highlights the importance of medication adherence for cardiovascular health.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Statins are crucial for reducing cardiovascular morbidity and mortality.
  • Poor patient adherence to statin therapy is a significant challenge, with many patients discontinuing medication early or not taking prescribed doses.
  • Understanding the impact of adherence levels on cardiovascular events is vital for optimizing treatment outcomes.

Purpose of the Study:

  • To assess the relationship between adherence to statin medication and the occurrence of nonfatal coronary artery disease (CAD).
  • To quantify the risk reduction associated with high statin adherence in a large patient cohort.

Main Methods:

  • A cohort of 20,543 patients newly treated with statins was analyzed using administrative healthcare databases.
  • A nested case-control design was employed to investigate nonfatal CAD events.
  • Statin adherence was defined as using >=90% of prescribed doses, and outcomes were analyzed using conditional logistic regression.

Main Results:

  • Patients with adherence >=90% for over one year experienced fewer nonfatal CAD events (RR 0.81; 95% CI 0.67-0.97) compared to those with <90% adherence.
  • Male gender, welfare recipient status, and newly diagnosed hypertension or diabetes were identified as risk factors for CAD.

Conclusions:

  • Adherence to statin therapy exceeding 90% for at least one year is associated with a significant decrease in nonfatal coronary artery disease events.
  • Optimizing patient adherence to statins is a key strategy for preventing cardiovascular events.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...